Evaluation of the Effect of Treatment of Latent Tuberculosis Infection on QuantiFERON-TB Gold Assay Results

To evaluate the utility of the QuantiFERON-TB Gold assay for monitoring latent tuberculosis treatment efficacy, the assay was performed serially for healthcare workers receiving isoniazid therapy. After 9 months of isoniazid therapy, all of these healthcare workers remained QuantiFERON-TB Gold positive, and cellular proliferation assays revealed persistently strong purified protein derivative responses. These results do not support the use of the QuantiFERON-TB Gold assay to monitor therapy.

[1]  K. Higuchi,et al.  Interferon‐γ responses after isoniazid chemotherapy for latent tuberculosis , 2008, Respirology.

[2]  N. Pollock,et al.  Identification of Mycobacterium tuberculosis Ornithine Carboamyltransferase in Urine as a Possible Molecular Marker of Active Pulmonary Tuberculosis , 2008, Clinical and Vaccine Immunology.

[3]  T. Barkham,et al.  Latent tuberculosis infection treatment and T-cell responses to Mycobacterium tuberculosis-specific antigens. , 2007, American journal of respiratory and critical care medicine.

[4]  G. Ippolito,et al.  Isoniazid prophylaxis differently modulates T-cell responses to RD1-epitopes in contacts recently exposed to Mycobacterium tuberculosis: a pilot study , 2007, Respiratory research.

[5]  J. Deeks,et al.  Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis. , 2006, American journal of respiratory and critical care medicine.

[6]  R. Joshi,et al.  Persistently elevated T cell interferon-γ responses after treatment for latent tuberculosis infection among health care workers in India: a preliminary report , 2006, Journal of occupational medicine and toxicology.

[7]  R. Wilkinson,et al.  Effect of treatment of latent tuberculosis infection on the T cell response to Mycobacterium tuberculosis antigens. , 2006, The Journal of infectious diseases.

[8]  L. Lambert,et al.  Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. , 2005, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[9]  B. Metchock,et al.  Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. , 2005, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.